Latest news with #TurningPointBrands
Yahoo
07-05-2025
- Business
- Yahoo
Turning Point Brands: Q1 Earnings Snapshot
LOUISVILLE, Ky. (AP) — LOUISVILLE, Ky. (AP) — Turning Point Brands, Inc. (TPB) on Wednesday reported profit of $14.4 million in its first quarter. The Louisville, Kentucky-based company said it had profit of 79 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 91 cents per share. The company posted revenue of $106.4 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TPB at
Yahoo
02-05-2025
- Business
- Yahoo
Is Turning Point Brands, Inc. (TPB) Among the Best Tobacco and Cigarette Stocks to Buy Now?
We recently compiled a list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. In this article, we are going to take a look at where Turning Point Brands, Inc. (NYSE:TPB) stands against the other Tobacco and Cigarette stocks. Cigarette and tobacco stocks are companies that produce and sell cigars, snuff, chewing tobacco, cigarettes, e-cigarettes, and all other tobacco products. The tobacco industry has long been a huge winner for investors. Tobacco companies were among the top performers during the 20th century because of their reputation for providing investors with substantial dividend yields as well as their addictive, extremely profitable, and recession-proof product. However, tobacco firms now confront a different set of challenges. Globally, smoking rates have been progressively declining, particularly in the United States, as a result of growing legislation and health concerns. The industry has attempted to shift to next-generation products as a result. Some people believe that e-cigarettes, vaporizers, and chewable nicotine pouches are healthier options since they avoid some of the negative aspects of smoking cigarettes, such as unpleasant odors. Some companies are expanding beyond tobacco, working with cannabis businesses to capitalize on the potential development in a market that shares numerous similarities with tobacco. There are other hazards associated with tobacco stocks, such as heightened regulation and a decline in smoking rates. According to the Centers for Disease Control and Prevention, the number of tobacco farms in the United States decreased from 93,530 in 1997 to roughly 3,000 in 2022. Nonetheless, the USA was the world's fifth-largest producer of tobacco in 2021, harvesting 431.6 million pounds in 2022, compared to 1.74 billion pounds in 1997. Seventy-seven percent of U.S. production came from North Carolina or Kentucky. Price reductions accounted for $5.7 billion (72%) of the $8.6 billion tobacco businesses spent on advertising in 2022, which included $572.7 million for smokeless tobacco and $8.01 billion for cigarettes. Marketing costs for e-cigarettes came to $859.4 million in 2021. Sales of cigarette packs fell from 12.5 billion to 9.1 billion packs between 2015 and 2021, a 27% decrease. In 2024, the average cigarette tax in each state was $1.93, while the federal tax was $1.01. Despite the industry's weak revenue and profit development, investors continue to be drawn to these stocks due to their consistent dividends, profitability, and solid profit margins. Investors believe that stronger growth will eventually be catalyzed by next-generation products. However, on April 2, 2025, the U.S. Supreme Court upheld the FDA's decision to deny approval for flavored e-cigarettes in a major decision. According to Justice Samuel Alito, vape producers were given 'adequate notice' of the FDA's review criteria. In this case, businesses like Vapetasia and Triton Distribution applied for certification for products such as 'Mother's Milk and Cookies' and 'Killer Kustard Blueberry.' The FDA has been regulating vaping products since 2016, claiming that flavored vapes represent a health concern and may encourage young people to use tobacco. More than 2.1 million youths in the US reported using e-cigarettes in 2023, with 10% of high school students vaping. The FDA has rejected thousands of flavored products and has only approved tobacco and menthol flavors. One specific issue, marketing plan consideration, was returned to lower courts after the Supreme Court reversed the 5th Circuit's prior criticism of the FDA's changing criteria. Companies that promote unapproved products risk 'civil and criminal penalties,' the FDA warned. A worker athlete with a rolling paper held in hand, smoking from the finished cigar. For this article, we sifted through the online rankings to form an initial list of the 15 Tobacco and Cigarette Stocks. We have also included e-cigarette and cannabis companies. From the resultant dataset, we chose 10 stocks with the highest number of hedge fund investors, using Insider Monkey's database of 1009 hedge funds in Q4 2024 to gauge hedge fund sentiment for stocks. We have used the stock's market cap as of April 25, 2025, as a tie-breaker in case two or more stocks have the same number of hedge funds invested. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here). Number of Hedge Fund Holders: 30 In the United States, Turning Point Brands, Inc. (NYSE:TPB) manufactures, markets, and distributes consumer goods, including other tobacco products (OTP). The company provides a wide range of items across the OTP spectrum, such as premium cigarette papers, make-your-own cigar wraps, cigars, liquid vapor products, tobacco vaporizers, and moist snuff tobacco. It is divided into two business segments: Stoker's products and Zig-Zag products. The Zig-Zag product category brings in the majority of revenue for the business. The stock soared by more than 108% in the past year, making it on our list of the Best Tobacco Stocks. Turning Point Brands, Inc. (NYSE:TPB) had a strong Q4 2024 due to strong core business execution. The firm's management gave encouraging advice and unveiled new metrics that showed the expansion of its tobacco-free nicotine pouches, a promising market-share-gaining area. Alliance Global Partners maintained its Buy rating on Turning Point Brands, Inc. (NYSE:TPB) shares and increased its price objective from $80 to $85 for the company. In a research note, the analyst informs investors that the company's Q4 sales and EBITDA figures were at the upper end of its tentative range. According to the company, net-for-net, the results are encouraging, and it anticipates that 2025 will be the firm's statement year in the pouch category, giving investors confidence that it can repeat its strategy of acquiring market share in a large tobacco-dominated category, as it did with Stoker's. Overall, TPB ranks 3rd on our list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. While we acknowledge the potential of Tobacco and Cigarette companies, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than TPB but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
23-04-2025
- Business
- Yahoo
Turning Point Brands to Host Q1 Conference Call
LOUISVILLE, Ky., April 23, 2025--(BUSINESS WIRE)--Turning Point Brands, Inc. (NYSE: TPB) announced the date and time for its conference call to review 1st quarter 2025 results. The conference call will be on Wednesday, May 7, 2025 at 9:30 a.m. Eastern. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free)(646) 307-1963 (International)Event ID: 6640134 Participants should dial in at least 10 minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at The replay of the webcast will be available on the site two hours following the call. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker's®, FRE®, and ALP®. TPB's products are available in more than 220,000 retail outlets in North America and on sites such as and For the latest news and information about TPB and its brands, please visit View source version on Contacts ir@ Sign in to access your portfolio
Yahoo
27-03-2025
- Business
- Yahoo
Turning Point Brands (NYSE:TPB) Knows How To Allocate Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Speaking of which, we noticed some great changes in Turning Point Brands' (NYSE:TPB) returns on capital, so let's have a look. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on Turning Point Brands is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.20 = US$88m ÷ (US$493m - US$45m) (Based on the trailing twelve months to December 2024). Thus, Turning Point Brands has an ROCE of 20%. On its own that's a fantastic return on capital, though it's the same as the Tobacco industry average of 20%. Check out our latest analysis for Turning Point Brands In the above chart we have measured Turning Point Brands' prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Turning Point Brands for free. Turning Point Brands has not disappointed with their ROCE growth. Looking at the data, we can see that even though capital employed in the business has remained relatively flat, the ROCE generated has risen by 46% over the last five years. Basically the business is generating higher returns from the same amount of capital and that is proof that there are improvements in the company's efficiencies. On that front, things are looking good so it's worth exploring what management has said about growth plans going forward. In summary, we're delighted to see that Turning Point Brands has been able to increase efficiencies and earn higher rates of return on the same amount of capital. And a remarkable 204% total return over the last five years tells us that investors are expecting more good things to come in the future. In light of that, we think it's worth looking further into this stock because if Turning Point Brands can keep these trends up, it could have a bright future ahead. If you'd like to know about the risks facing Turning Point Brands, we've discovered 1 warning sign that you should be aware of. If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
22-03-2025
- Business
- Yahoo
TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside
After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and share prices have largely followed suit. Here, we'll examine three profitable and cheap cannabis-related stocks that offer investors long-term value and potential upside: Turning Point Brands (TPB), Aurora Cannabis (ACB), and Jazz Pharmaceuticals (JAZZ). Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Having been illegal for decades, cannabis is seeing the light of day following spates of deregulation across the U.S., Canada, Australia, and Europe over the past decade. Cannabis stocks, otherwise known as pot stocks, have understandably emerged to mop up the huge pent-up demand for cannabis products. Whether it be medicinal, industrial, or recreational, the cannabis market is now a commercial entity being monetized across the U.S. and Canada. In the U.S., after an initial sentiment boost following legalization, the cannabis market has cooled. The AdvisorShares Pure US Cannabis ETF (MJUS), which tracks U.S. cannabis stocks, traded at over $50 a share in early 2021 but now trades for just $2.68. Tilray Brands (TLRY), one of the earliest and most hyped pure-play publicly traded cannabis companies, traded for over $145 a share in late 2018 but today is priced at less than a dollar. It's hard to understate how poorly many of these pure-play cannabis stocks have performed. While it has been a difficult space to invest in, the industry still harbors potential — recreational marijuana is now legal in 24 U.S. states (plus Washington D.C.), while medical marijuana is legal in 39 (that said, it's important to note that it is still classified as a Schedule 1 Drug by the Federal Government). Grand View Research predicts the global legal cannabis market will grow to $102 billion by 2030, suitable for an impressive 25.5% CAGR. For investors still interested in the industry and gaining exposure to the space, the good news is that the sector has matured, and there are plenty of innovative ways to invest in it rather than speculating on questionable stocks with little earnings. Turning Point Brands (TPB) is an interesting way to enter the cannabis space. While it is not a pure-play cannabis company, it sells Zig-Zag rolling papers and is part of the industry. It is also included in New Cannabis Ventures' Global Cannabis Stock Index. Unlike many of its peers, it has performed quite well, nearly doubling over the past year. However, unlike some of these peers, Turning Point is profitable, and even after this massive rally, it is actually reasonably cheap, trading for under 19x 2025 earnings estimates, a slight discount to the broader market. Turning Point offers both momentum and value and has much potential going forward. In addition to rolling papers, the company sells nicotine pouches under the FRE brand. Most notably, last year, Turning Point launched a high-profile 50/50 joint venture with Tucker Carlson Media to start a new nicotine pouch brand called ALP. This move garnered significant publicity as Tucker Carlson has a significant following as one of the most popular (if polarizing) figures in U.S. media, giving ALP a large platform and high visibility. Nicotine pouches have rapidly gained popularity in recent years, with products like Zyn becoming a major hit for Philip Morris (PM). Between the popularity of nicotine pouches and Carlson's ability to sell ALP to his audience, ALP has a lot of growth potential going forward. I like Turning Point as a smart way to play the cannabis space because it offers strong diversification. Investors get exposure to cannabis through Zig-Zag and diversification into other revenue streams thanks to its nicotine pouch businesses. On Wall Street, TPB earns a Strong Buy consensus rating based on three Buys, zero Holds, and zero Sell ratings assigned in the past three months. The average analyst TPB stock price target of $81.67 implies a 43% upside potential from current levels. Aurora Cannabis was among the buzziest stocks of the initial cannabis stock boom, reaching nearly $150 a share in 2021. However, the stock has fallen precipitously since then, losing nearly 95% of its value over the past five years. However, there are some green shoots of life here. After years of losses, the stock is up nearly 20% over the past year. The company recently reported a record adjusted EBITDA of $7 million last quarter as its pivot from focusing on the Canadian recreational market to the more lucrative and high-margin international medical market began to bear fruit. This was evidenced by revenue from the global market surging 93% and surpassing Canadian revenue for the first time. In addition to becoming profitable, Aurora is also reasonably cheap—shares trade for a very reasonable 17.8x 2025 earnings. While this is still a speculative stock based on its spotty history, its valuation and swing to record profitability based on its strategic shift make it an intriguing speculative opportunity for risk-averse investors. Plus, sell-side analysts foresee monster upside potential ahead. Turning to Wall Street, ACB earns a Moderate Buy consensus rating based on two Buys, one Hold, and zero Sell ratings assigned in the past three months. The average analyst ACB stock price target of $7.10 implies a 58% upside potential from current levels. Lastly, let's examine Jazz Pharmaceuticals ($ JAZZ) as a different way to gain exposure to the cannabis market. To be clear, Jazz Pharmaceuticals is not a pure play on cannabis as it is a diversified biotech company with an $8.5 billion market cap. However, it offers significant exposure to cannabis thanks to its 2021 acquisition of GW Pharmaceuticals, which added CBD-based epilepsy drug Epidiolex to its portfolio. The successful drug is now approaching $1 billion in annual sales and is approved in dozens of countries worldwide. In addition to Epidiolex, Jazz's product portfolio includes many other drugs focused on sleep disorders and oncology. I like that this gives investors diversification and additional revenue streams outside of cannabis. What's more, shares of Jazz are pretty cheap. With analysts projecting the company to earn $23.42 per share in 2025, the stock trades for just six times 2025 earnings estimates. Turning to Wall Street, JAZZ earns a Strong Buy consensus rating based on seventeen Buys, one Hold, and zero Sell ratings assigned in the past three months. The average analyst JAZZ stock price target of $193.82 implies a 40% upside potential from current levels. While many cannabis stocks have developed a bad reputation after falling drastically from their lofty 2021 highs, there are pockets of value here if you know where to look. Many weaker players have gone by the wayside, while the stronger companies have matured and become more profitable. I like Turning Point Brands, Aurora Cannabis, and Jazz Pharmaceuticals as three attractive ways to play the market — all three are quite different, but what they have in common is that they are all profitable, and they all trade for inexpensive valuations. Furthermore, analysts project a significant potential upside of over 40% or more for all three over the next 12 months, highlighting their strong potential. Disclosure Questions or Comments about the article? Write to editor@ Sign in to access your portfolio
